Literature DB >> 20443832

BMP-2 and FGF-2 synergistically facilitate adoption of a cardiac phenotype in somatic bone marrow c-kit+/Sca-1+ stem cells.

Brent R Degeorge1, Marc Rosenberg, Volker Eckstein, Erhe Gao, Nicole Herzog, Hugo A Katus, Walter J Koch, Norbert Frey, Patrick Most.   

Abstract

The aim of this study was to explore the effect of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2)- paracrine factors implicated in both cardiac embryogenesis and cardiac repair following myocardial infarction (MI)-on murine bone marrow stem cell (mBMSC) differentiation in an ex vivo cardiac microenvironment. For this purpose, green fluorescent protein (GFP) expressing hematopoietic lineage negative (lin-) c-kit ligand (c-kit) and stem cell antigen-1 (Sca-1) positive (GFP-lin-/c-kit+/sca+) mBMSC were co-cultured with neonatal rat ventricular cardiomyocytes (NVCMs). GFP+ mBMSC significantly induced the expression of BMP-2 and FGF-2 in NVCMs, and approximately 4% GFP+ mBMSCs could be recovered from the co-culture at day 10. The addition of BMP-2 in concert with FGF-2 significantly enhanced the amount of integrated GFP+ mBMSCs by 5-fold ( approximately 20%), whereas the addition of anti-BMP-2 and/or anti-FGF-2 antibodies completely abolished this effect. An analysis of calcium cycling revealed robust calcium transients in GFP+ mBMSCs treated with BMP-2/FGF-2 compared to untreated co-cultures. BMP-2 and FGF-2 addition led to a significant induction of early (NK2 transcription factor related, locus 5; Nkx2.5, GATA binding protein 4; GATA-4) and late (myosin light chain kinase [MLC-2v], connexin 43 [Cx43]) cardiac marker mRNA expression in mBMSCs following co-culture. In addition, re-cultured fluorescence-activated cell sorting (FACS)-purified BMP-2/FGF-2-treated mBMSCs revealed robust calcium transients in response to electrical field stimulation which were inhibited by the L-type calcium channel (LTCC) inhibitor, nifedipine, and displayed caffeine-sensitive intracellular calcium stores. In summary, our results show that mBMSCs can adopt a functional cardiac phenotype through treatment with factors essential to embryonic cardiogenesis that are induced after cardiac ischemia. This study provides the first evidence that mBMSCs with long-term self-renewal potential possess the capability to serve as a functional cardiomyocyte precursor through the appropriate paracrine input and cross-talk within an appropriate cardiac microenvironment.

Entities:  

Keywords:  BMP-2; FGF-2; mBMSCs; paracrine signalling

Mesh:

Substances:

Year:  2008        PMID: 20443832      PMCID: PMC2863128          DOI: 10.1111/j.1752-8062.2008.00034.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  43 in total

Review 1.  Biology of hematopoietic stem cells and progenitors: implications for clinical application.

Authors:  Motonari Kondo; Amy J Wagers; Markus G Manz; Susan S Prohaska; David C Scherer; Georg F Beilhack; Judith A Shizuru; Irving L Weissman
Journal:  Annu Rev Immunol       Date:  2002-12-17       Impact factor: 28.527

Review 2.  Prometheus's vulture and the stem-cell promise.

Authors:  Nadia Rosenthal
Journal:  N Engl J Med       Date:  2003-07-17       Impact factor: 91.245

3.  Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells.

Authors:  Alexis S Bailey; Shuguang Jiang; Michael Afentoulis; Christina I Baumann; David A Schroeder; Susan B Olson; Melissa H Wong; William H Fleming
Journal:  Blood       Date:  2003-09-04       Impact factor: 22.113

4.  N-cadherin localization in early heart development and polar expression of Na+,K(+)-ATPase, and integrin during pericardial coelom formation and epithelialization of the differentiating myocardium.

Authors:  K K Linask
Journal:  Dev Biol       Date:  1992-05       Impact factor: 3.582

5.  Polyethylene glycol-mediated fusion between primary mouse mesenchymal stem cells and mouse fibroblasts generates hybrid cells with increased proliferation and altered differentiation.

Authors:  M Q Islam; L da S Meirelles; N B Nardi; P Magnusson; K Islam
Journal:  Stem Cells Dev       Date:  2006-12       Impact factor: 3.272

6.  Murine embryonic stem cells secrete cytokines/growth modulators that enhance cell survival/anti-apoptosis and stimulate colony formation of murine hematopoietic progenitor cells.

Authors:  Ying Guo; Barbara Graham-Evans; Hal E Broxmeyer
Journal:  Stem Cells       Date:  2005-12-08       Impact factor: 6.277

7.  Stem cell differentiation requires a paracrine pathway in the heart.

Authors:  Atta Behfar; Leonid V Zingman; Denice M Hodgson; Jean-Michel Rauzier; Garvan C Kane; Andre Terzic; Michel Pucéat
Journal:  FASEB J       Date:  2002-10       Impact factor: 5.191

8.  Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.

Authors:  Patrick Most; Hanna Seifert; Erhe Gao; Hajime Funakoshi; Mirko Völkers; Jörg Heierhorst; Andrew Remppis; Sven T Pleger; Brent R DeGeorge; Andrea D Eckhart; Arthur M Feldman; Walter J Koch
Journal:  Circulation       Date:  2006-09-04       Impact factor: 29.690

9.  Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes.

Authors:  Cornel Badorff; Ralf P Brandes; Rüdiger Popp; Stefan Rupp; Carmen Urbich; Alexandra Aicher; Ingrid Fleming; Rudi Busse; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

10.  A stem cell molecular signature.

Authors:  Natalia B Ivanova; John T Dimos; Christoph Schaniel; Jason A Hackney; Kateri A Moore; Ihor R Lemischka
Journal:  Science       Date:  2002-09-12       Impact factor: 47.728

View more
  8 in total

1.  BMP Signaling Mediated by BMPR1A in Osteoclasts Negatively Regulates Osteoblast Mineralization Through Suppression of Cx43.

Authors:  Ce Shi; Honghao Zhang; Ke'ale Louie; Yuji Mishina; Hongchen Sun
Journal:  J Cell Biochem       Date:  2016-09-30       Impact factor: 4.429

Review 2.  S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapy.

Authors:  Carolin Kraus; David Rohde; Christian Weidenhammer; Gang Qiu; Sven T Pleger; Mirko Voelkers; Melanie Boerries; Andrew Remppis; Hugo A Katus; Patrick Most
Journal:  J Mol Cell Cardiol       Date:  2009-06-16       Impact factor: 5.000

3.  Bone morphogenetic protein-2/-4 upregulation promoted by endothelial cells in coculture enhances mouse embryoid body differentiation.

Authors:  Dodanim Talavera-Adame; Ankur Gupta; Silvia Kurtovic; Kira L Chaiboonma; Vaithilingaraja Arumugaswami; Donald C Dafoe
Journal:  Stem Cells Dev       Date:  2013-09-24       Impact factor: 3.272

4.  A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse.

Authors:  Erhe Gao; Yong Hong Lei; Xiying Shang; Z Maggie Huang; Lin Zuo; Matthieu Boucher; Qian Fan; J Kurt Chuprun; Xin L Ma; Walter J Koch
Journal:  Circ Res       Date:  2010-10-21       Impact factor: 17.367

5.  Coculture with hematopoietic stem cells protects cardiomyocytes against apoptosis via paracrine activation of AKT.

Authors:  Mark Rosenberg; Matthias Lutz; Constantin Kühl; Rainer Will; Volker Eckstein; Jutta Krebs; Hugo A Katus; Norbert Frey
Journal:  J Transl Med       Date:  2012-06-06       Impact factor: 5.531

6.  Exogenous expression of human apoA-I enhances cardiac differentiation of pluripotent stem cells.

Authors:  Kwong-Man Ng; Yee-Ki Lee; Wing-Hon Lai; Yau-Chi Chan; Man-Lung Fung; Hung-Fat Tse; Chung-Wah Siu
Journal:  PLoS One       Date:  2011-05-11       Impact factor: 3.240

Review 7.  Cardiac regeneration: different cells same goal.

Authors:  Phil Barnett; Maurice J B van den Hoff
Journal:  Med Biol Eng Comput       Date:  2011-04-16       Impact factor: 2.602

Review 8.  Cardiac Remodeling: Endothelial Cells Have More to Say Than Just NO.

Authors:  Vincent F M Segers; Dirk L Brutsaert; Gilles W De Keulenaer
Journal:  Front Physiol       Date:  2018-04-11       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.